Dabigatran ethyl ester - CAS 429658-95-7
Catalog number: 429658-95-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Dabigatran ethyl ester is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity. Dabigatran provides a stable anticoagulation effect without any need to perform periodical laboratory.
Publictions citing BOC Sciences Products
  • >> More
1.Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2).
Michaelis S1, Marais A, Schrey AK, Graebner OY, Schaudt C, Sefkow M, Kroll F, Dreger M, Glinski M, Koester H, Metternich R, Fischer JJ. J Med Chem. 2012 Apr 26;55(8):3934-44. doi: 10.1021/jm3001339. Epub 2012 Apr 17.
Recent studies have revealed that compounds believed to be highly selective frequently address multiple target proteins. We investigated the protein interaction profile of the widely prescribed thrombin inhibitor dabigatran (1), resulting in the identification and subsequent characterization of an additional target enzyme. Our findings are based on an unbiased functional proteomics approach called capture compound mass spectrometry (CCMS) and were confirmed by independent biological assays. 1 was shown to specifically bind ribosyldihydronicotinamide dehydrogenase (NQO2), a detoxification oxidoreductase. Molecular dockings predicted and biological experiments confirmed that dabigatran ethyl ester (2) inhibits NQO2 even more effectively than the parent 1 itself. Our data show that 1 and 2 are inhibitors of NQO2, thereby revealing a possible new aspect in the mode of action of 1. We present a workflow employing chemical proteomics, molecular modeling, and functional assays by which a compound's protein-interaction profile can be determined and used to tune the binding affinity.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Thrombin Products

CAS 137339-65-2 Sfllrnpndkyepf

(CAS: 137339-65-2)

SFLLRNPNDKYEPF is a synthetic thrombin receptor agonist peptide and causes platelet aggregation (EC50 = 4 μM) and secretion .

CAS 429658-95-7 Dabigatran ethyl ester

Dabigatran ethyl ester
(CAS: 429658-95-7)

Dabigatran ethyl ester is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity. Dabigatran provides a stable anticoagulation effect w...

CAS 137215-12-4 odiparcil

(CAS: 137215-12-4)

Odiparcil is a novel thrombin inhibitor as a beta-d-thioxyloside analog originated by Fournier Pharma. It is also a Glycosaminoglycan stimulant. Research for th...

CAS 141396-28-3 Argatroban

(CAS: 141396-28-3)

Argatroban is an anticoagulant that is a direct thrombin inhibitor. Argatroban was approved in 2000 for prophylaxis or treatment of thrombosis in patients with ...

(CAS: 60503-05-1)

H-D-Phe-Pro-arginal is a thrombin inhibitor which is being developed by IVAX for the potential treatment of thromboembolic disorders. It has a similar efficacy ...

CAS 211915-06-9 Dabigatran Etexilate

Dabigatran Etexilate
(CAS: 211915-06-9)

Dabigatran etexilate(BIBR-1048) is the orally active prodrug of dabigatran; Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) with Ki va...

CAS 74863-84-6 Argatroban

(CAS: 74863-84-6)

Argatroban is an anticoagulant that is a small molecule direct thrombin inhibitor.


VE-1902 is a novel and selective inhibitor of thrombin. Study in vivo and in vitro showed that VE-1902 inhibits thrombin via binding to it reversibly.

CAS 83997-16-4 GYKI 14166

GYKI 14166
(CAS: 83997-16-4)

Efegatran is a thrombin inhibitor under the development of Eli Lilly. It can be used for the treatment of thromboembolic disorders. No development reported was ...

CAS 211914-51-1 Dabigatran

(CAS: 211914-51-1)

Dabigatran is a very potent anticoagulant, shows that the terminal phenyl can be substituted by the more hydrophilic 2-pyridyl group without substantial loss of...

CAS 496775-62-3 Eltrombopag Olamine

Eltrombopag Olamine
(CAS: 496775-62-3)

Eltrombopag is a is an agonist of the c-mpl (TpoR) receptor used as treatment for thrombocytopenia.It has been developed for certain conditions that lead to thr...

(CAS: 69201-89-4)

GYKI14451 is a synthetic tripeptide inhibitor of thrombin. It has anti-atherosclerotic activity.

CAS 192939-46-1 Ximelagatran

(CAS: 192939-46-1)

Ximelagatran, an ester prodrug of melagatran, with anticoagulant effect, is the first member of direct thrombin inhibitors that can be taken orally.

CAS 30827-99-7 AEBSF HCl

(CAS: 30827-99-7)

AEBSF is a water soluble, irreversible serine protease inhibitor; inhibits proteases like chymotrypsin, kallikrein, plasmin, thrombin, and trypsin.

CAS 871576-03-3 Flovagatran

(CAS: 871576-03-3)

Flovagatran is a thrombin inhibitor originated by Trigen Holdings AG. In Dec 2010, Phase-II for Thrombosis was discontinued.

CAS 872728-81-9 Dabigatran etexilate mesylate

Dabigatran etexilate mesylate
(CAS: 872728-81-9)

Dabigatran etexilate mesylate is the orally active prodrug of dabigatran. It is a reversible and selective, direct thrombin inhibitor (DTI).

CAS 138068-37-8 Lepirudin

(CAS: 138068-37-8)

Lepirudin is an anticoagulant that acts as a direct thrombin inhibitor. Lepirudin binds to both free and clot-bound thrombin. Lepirudin is approved for the trea...

GYKI-14451 sulfate
(CAS: 83861-29-4)

GYKI-14451 is a synthetic tripeptide inhibitor of thrombin.It has anti-atherosclerotic activity.

Bivalirudin Trifluoroacetate

Bivalirudin is a specific and reversible bivalent direct thrombin inhibitor. Bivalirudin specifically binds to both the catalytic site and to the anion-binding ...

Chemical Structure

CAS 429658-95-7 Dabigatran ethyl ester

Quick Inquiry

Verification code

Featured Items